Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · see citing works

Arginine metabolism: nitric oxide and beyond

WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811 · see citing works

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683 · see citing works

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683 · see citing works

Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry

Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., & Mann, M. (1996) · Nature · doi:10.1038/379466a0 · Cited by 1,674 · see citing works

Targeting cancer metabolism: a therapeutic window opens

Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,409 · see citing works

Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

Zea, A. H., Rodrı́guez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D. F., Quiceno, D. G., Youmans, A. J., O’Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 852 · see citing works

Recent advances in arginine metabolism: roles and regulation of the arginases

Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485 · see citing works

Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

Broome, J. D. (1961) · Nature · doi:10.1038/1911114a0 · Cited by 461 · see citing works

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441 · see citing works

EVIDENCE THAT THE L -ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS

Broome, J. D. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.99 · Cited by 349 · see citing works

Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase

Iwamoto, S., Mihara, K., Downing, J. R., Pui, C., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336 · see citing works

Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle

Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 329 · see citing works

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers

Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 317 · see citing works

Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis

Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 316 · see citing works

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315 · see citing works

Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion

Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 279 · see citing works

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250 · see citing works

Asparagine Synthetase Chemotherapy

Richards, N. G. J., & Kilberg, M. S. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142520 · Cited by 244 · see citing works

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238 · see citing works

Requirement of argininosuccinate lyase for systemic nitric oxide production

Erez, A., Nagamani, S. C. S., Shchelochkov, O. A., Premkumar, M. H., Campeau, P. M., Chen, Y., Garg, H. K., Li, L., Mian, A., Bertin, T. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2544 · Cited by 233 · see citing works

Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells

Tsai, W.-B., Aiba, I., Long, Y., Lin, H., Feun, L. G., Savaraj, N., & Kuo, M. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3605 · Cited by 233 · see citing works

Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma

Glazer, E. S., Piccirillo, M., Albino, V., Giacomo, R. D., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., Rosa, V. D., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187 · see citing works

Adipocytes Cause Leukemia Cell Resistance to L -Asparaginase via Release of Glutamine

Ehsanipour, E. A., Sheng, X., Behan, J. W., Wang, X., Butturini, A. M., Avramis, V. I., & Mittelman, S. D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4402 · Cited by 185 · see citing works

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Szlosarek, P. W., Klampatsa, A., Pallaska, A., Sheaff, M. T., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P. C., Rudd, R., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181 · see citing works

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells

Scott, L., Lamb, J., Smith, S. H., & Wheatley, D. N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1353 · Cited by 178 · see citing works

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Takezawa, K., Okamoto, I., Okamoto, W., Takeda, M., Sakai, K., Tsukioka, S., Kuwata, K., Yamaguchi, H., Nishio, K., & Nakagawa, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.129 · Cited by 170 · see citing works

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma

Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167 · see citing works

Molecular profiling of platinum resistant ovarian cancer

Helleman, J., Jansen, M. P. H. M., Span, P. N., van Staveren, I. L., Massuger, L. F. A. G., Gelder, M. E. M., Sweep, F. C. G. J., Ewing, P. C., van der Burg, M. E. L., Stoter, G., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21599 · Cited by 165 · see citing works

Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity

Offman, M. N., Król, M., Patel, N. R., Krishnan, S., Liu, J., Saha, V., & Bates, P. A. (2010) · Blood · doi:10.1182/blood-2010-07-298422 · Cited by 164 · see citing works

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160 · see citing works

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

Righi, L., Papotti, M. G., Ceppi, P., Billè, A., Bacillo, E., Molinaro, L., Ruffini, E., Scagliotti, G. V., & Selvaggi, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9275 · Cited by 159 · see citing works

ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance

Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 154 · see citing works

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153 · see citing works

Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging

Allen, M. D., Luong, P., Hudson, C. D., Leyton, J., Delage, B., Ghazaly, E. A., Cutts, R. J., Yuan, M., Syed, N., Nigro, C. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1702 · Cited by 153 · see citing works

Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression

Sigmond, J., Backus, H. H. J., Wouters, D., Temmink, O. H., Jansen, G., & Peters, G. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00287-9 · Cited by 147 · see citing works

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146 · see citing works

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis

Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 144 · see citing works

Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4

Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 141 · see citing works

Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis

Gong, H., Zölzer, F., Recklinghausen, G. V., Havers, W., & Schweigerer, L. (2000) · Leukemia · doi:10.1038/sj.leu.2401763 · Cited by 138 · see citing works

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer

Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133 · see citing works

The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia

Truelove, E., Fielding, A. K., & Hunt, B. J. (2012) · Leukemia · doi:10.1038/leu.2012.290 · Cited by 130 · see citing works

Arginine stimulates intestinal cell migration through a focal adhesion kinase dependent mechanism

Rhoads, J. M., Chen, W., Gookin, J. L., Wu, G., Fu, Q., Blikslager, A. T., Rippe, R. A., Argenzio, R. A., Cance, W. G., Weaver, E. M., et al. (2004) · Gut · doi:10.1136/gut.2003.027540 · Cited by 124 · see citing works

In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini

Takaku, H., Takase, M., Abe, S., Hayashi, H., & Miyazaki, K. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510213 · Cited by 123 · see citing works

Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction

Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121 · see citing works

Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy

Sikora, A. G., Gelbard, A. H., Davies, M. A., Sano, D., Ekmekçioglu, S., Kwon, J., Hailemichael, Y., Jayaraman, P., Myers, J. N., Grimm, E. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3123 · Cited by 121 · see citing works

Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 120 · see citing works

Pegylated arginine deiminase: a novel anticancer enzyme agent

Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118 · see citing works

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117 · see citing works

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113 · see citing works

Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma

Savaraj, N., You, M., Wu, C., Wangpaichitr, M., Kuo, M. T., & Feun, L. G. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316995 · Cited by 108 · see citing works

Pegylated arginase I: a potential therapeutic approach in T-ALL

Hernandez, C. P., Morrow, K. D., Lopez-Barcons, L. A., Zabaleta, J., Sierra, R. A., Velasco, C., COLE, J. T., & Rodrı́guez, P. C. (2010) · Blood · doi:10.1182/blood-2009-12-258822 · Cited by 104 · see citing works

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

Yau, T. C. C., Cheng, P. N.-M., Chan, P., Chan, W., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9807-9 · Cited by 104 · see citing works

Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells

Zheng, L., MacKenzie, E. D., Karim, S. A., Hedley, A., Blyth, K., Kalna, G., Watson, D. G., Szlosarek, P., Frezza, C., & Gottlieb, E. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-12 · Cited by 103 · see citing works

A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia

Adam, J., Yang, M., Bauerschmidt, C., Kitagawa, M., O’Flaherty, L., Maheswaran, P., Özkan, G., Sahgal, N., Baban, D., Kato, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.006 · Cited by 97 · see citing works

Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth

Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 95 · see citing works

Arginine deiminase has multiple regulatory roles in the biology ofGiardia lamblia

Touz, M. C., Ropolo, A. S., Rivero, M. R., Vranych, C. V., Conrad, J. T., Svärd, S. G., & Nash, T. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.026963 · Cited by 94 · see citing works

Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target

Grimm, E. A., Sikora, A. G., & Ekmekçioglu, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1554 · Cited by 91 · see citing works

Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.

Edler, D., Kressner, U., Ragnhammar, P., Johnston, P. G., Magnusson, I., Glimelius, B. L. G., Påhlman, L., Lindmark, G. E., & Blomgren, H. (2000) · PubMed · Cited by 89 · see citing works

Arginine Stimulates cdx2-Transformed Intestinal Epithelial Cell Migration via a Mechanism Requiring Both Nitric Oxide and Phosphorylation of p70 S6 Kinase1,

Rhoads, J. M., Liu, Y., Niu, X., Surendran, S., & Wu, G. (2008) · Journal of Nutrition · doi:10.1093/jn/138.9.1652 · Cited by 82 · see citing works

Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis

Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76 · see citing works

Controlling cancer by restricting arginine availability–arginine-catabolizing enzymes as anticancer agents

Wheatley, D. N. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00002 · Cited by 74 · see citing works

Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase

Szlosarek, P. W., Luong, P., Phillips, M. M., Baccarini, M., Ellis, S. M., Szyszko, T. A., Sheaff, M. T., & Avril, N. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.1784 · Cited by 74 · see citing works

TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation

You, M., Savaraj, N., Kuo, M. T., Wangpaichitr, M., Varona-Santos, J., Wu, C., Nguyen, D. M., & Feun, L. G. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1518-1 · Cited by 72 · see citing works

Bioengineered Human Arginase I with Enhanced Activity and Stability Controls Hepatocellular and Pancreatic Carcinoma Xenografts

Glazer, E. S., Stone, E. M., Zhu, C., Massey, K. L., Hamir, A. N., & Curley, S. A. (2011) · Translational Oncology · doi:10.1593/tlo.10265 · Cited by 67 · see citing works

Depletion of Dietary Arginine Inhibits Growth of Metastatic Tumor

Yeatman, T. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410350066010 · Cited by 67 · see citing works

Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase

Shen, L.-J., Lin, W.-C., Beloussow, K., & Shen, W.-C. (2003) · Cancer Letters · doi:10.1016/s030-43835(02)00693-6 · Cited by 66 · see citing works

Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance

Lan, J., Tai, H., Lee, S., Chen, T., Huang, H., & Li, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1020-8 · Cited by 66 · see citing works

Aberrant regulation of argininosuccinate synthetase by TNF‐α in human epithelial ovarian cancer

Szlosarek, P. W., Grimshaw, M. J., Wilbanks, G. D., Hagemann, T., Wilson, J. L., Burke, F., Stamp, G., & Balkwill, F. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22666 · Cited by 61 · see citing works

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma

Melaiu, O., Cristaudo, A., Melissari, E., Russo, M. D., Bonotti, A., Bruno, R., Foddis, R., Gemignani, F., Pellegrini, S., & Landi, S. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.003 · Cited by 60 · see citing works

ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer

Kim, R. H., Bold, R. J., & Kung, H.-J. (2009) · Autophagy · doi:10.4161/auto.5.4.8252 · Cited by 56 · see citing works

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells

Tanios, R. F., Bekdash, A., Kassab, E., Stone, E. M., Georgiou, G., Frankel, A. E., & Abi‐Habib, R. J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.08.007 · Cited by 55 · see citing works

Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiation

Gong, H., Pöttgen, C., Stüben, G., Havers, W., Stuschke, M., & Schweigerer, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11298 · Cited by 53 · see citing works

Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia

Morrow, K. D., Hernandez, C. P., Raber, P. L., Valle, L. D., Wilk, A. M., Majumdar, S., Wyczechowska, D. D., Krzysztof Reiss, F., & Rodrı́guez, P. C. (2012) · Leukemia · doi:10.1038/leu.2012.247 · Cited by 50 · see citing works

Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation

Vynnytska‐Myronovska, B., Bobak, Y. P., Garbe, Y., Dittfeld, C., Stasyk, O. V., & Kunz‐Schughart, L. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26221 · Cited by 48 · see citing works

Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells

Vynnytska‐Myronovska, B., Mayevska, O. M., Kurlishchuk, Y. V., Bobak, Y. P., & Stasyk, O. V. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833e0334 · Cited by 46 · see citing works

The Effects of Arginine Deficiency on Lymphoma Cells

Storr, J. M., & Burton, A. F. (1974) · British Journal of Cancer · doi:10.1038/bjc.1974.112 · Cited by 44 · see citing works

Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?

Douer, D. (2008) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.08.004 · Cited by 42 · see citing works

Glutamine and arginine affect Caco-2 cell proliferation by promotion of nucleotide synthesis

Yamauchi, K., Komatsu, T., Kulkarni, A. D., Ohmori, Y., Minami, H., Ushiyama, Y., Nakayama, M., & Yamamoto, S. (2002) · Nutrition · doi:10.1016/s0899-9007(01)00788-2 · Cited by 40 · see citing works

Favorable remission induction rate with twice weekly doses of L-asparaginase.

Jaffe, N., Traggis, D., Das, L. M. V., Frauenberger, G., Hann, H. W., Kim, B. S., & Bishop, Y. M. M. (1973) · PubMed · Cited by 39 · see citing works

Recombinant Human Arginase Toxicity in Mice Is Reduced by Citrulline Supplementation

Mauldin, J., Zeinali, I., Kleypas, K., Woo, J. H., Blackwood, R. S., Jo, C.-H., Stone, E. M., Georgiou, G., & Frankel, A. E. (2012) · Translational Oncology · doi:10.1593/tlo.11262 · Cited by 38 · see citing works

Attenuation of Argininosuccinate Lyase Inhibits Cancer Growth via Cyclin A2 and Nitric Oxide

Huang, H.-L., Hsu, H., Shieh, S.-C., Chang, Y.-S., Chen, W.-C., Cho, C.-Y., Teng, C., Su, I., Hung, W.-C., & Lai, M.-D. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0863 · Cited by 37 · see citing works

Some aspects of the role of arginine and arginase in mouse carcinoma 63.

Sj, B., & Lasnitzki, I. (1947) · PubMed · Cited by 37 · see citing works

Amino acid regulation of mammalian gene expression in the intestine

Brasse‐Lagnel, C., Lavoinne, A., & Husson, A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.021 · Cited by 36 · see citing works

The influence of arginine upon the growth rate of a transplantable tumour in the mouse

Gilroy, E. (1930) · Biochemical Journal · doi:10.1042/bj0240589 · Cited by 35 · see citing works

Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells

Agrawal, V., Woo, J. H., Mauldin, J., Jo, C., Stone, E. M., Georgiou, G., & Frankel, A. E. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834ae42b · Cited by 34 · see citing works

Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment

Braas, D., Ahler, E., Tam, B., Nathanson, D. A., Riedinger, M., Benz, M., Smith, K. B., Eilber, F. C., Witte, O. N., Tap, W. D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0197 · Cited by 32 · see citing works

Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma

Chow, A. K.-M., Ng, L., Li, H. S., Cheng, C. W., Lam, C. S. C., Yau, T. C. C., Cheng, P., Fan, S. T., Poon, R. T. P., & Pang, R. W. C. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803988002 · Cited by 32 · see citing works

Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer

Ceppi, P., Rapa, I., Iacono, M. L., Righi, L., Giorcelli, J., Pautasso, M., Billè, A., Ardissone, F., Papotti, M. G., & Scagliotti, G. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.26188 · Cited by 30 · see citing works

Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells

Wang, Z., Shi, X., Li, Y., Zeng, X. L., Fan, J., Sun, Y., Xian, Z., Zhang, G., Wang, S., Hu, H., et al. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5118-0 · Cited by 30 · see citing works

Alternatively Activated Macrophage Possess Antitumor Cytotoxicity That Is Induced by IL-4 and Mediated by Arginase-1

Ellyard, J. I., Quah, B., Simson, L., & Parish, C. R. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181cd8746 · Cited by 30 · see citing works

Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy

Stone, E. M., Chantranupong, L., Gonzalez, C., O’Neal, J. F., Rani, M., Berg, C. L. V. D., & Georgiou, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.097 · Cited by 28 · see citing works

Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling

Fu, Y., Zhang, H., Ding, M., Li, Y., Fu, X., Yu, Z., & Meadows, G. G. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-5515-y · Cited by 27 · see citing works

Short-term arginine deprivation results in large-scale modulation of hepatic gene expression in both normal and tumor cells: microarray bioinformatic analysis

Leong, H. X., Simkevich, C. P., Lesieur-Brooks, A. M., Lau, B. W., Fugère, C., Sabo, E., & Thompson, N. L. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-37 · Cited by 23 · see citing works

Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment

Fung, K.-L., & Chi-Fung, C. G. (2013) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-2-11 · Cited by 20 · see citing works

Effect of Arginine Deficiency on Synthesis of DNA and Immunoglobulin Receptor of Burkitt Lymphoma Cells

Osunkoya, B. O., Adler, W. H., & Smith, R. T. (1970) · Nature · doi:10.1038/227398a0 · Cited by 18 · see citing works

Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Stelter, L., Evans, M. J., Jungbluth, A. A., ZANZONICO, P. B., Ritter, G., Ku, T. W., Rosenfeld, E., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092973 · Cited by 18 · see citing works

Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.

Stelter, L., Evans, M. J., Jungbluth, A. A., Longo, V. A., ZANZONICO, P. B., Ritter, G., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2013) · PubMed · Cited by 14 · see citing works

Evaluation of Arginine Deiminase Treatment in Melanoma Xenografts Using 18F-FLT PET

Stelter, L., Fuchs, S., Jungbluth, A. A., Ritter, G., Longo, V. A., ZANZONICO, P. B., Raschzok, N., Sauer, I. M., Bomalaski, J. S., & Larson, S. M. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0655-6 · Cited by 13 · see citing works

No Child Left Behind in SDHB Testing for Paragangliomas and Pheochromocytomas

Schiffman, J. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8695 · Cited by 13 · see citing works

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells

Wu, F. L., Liang, Y.-F., Chang, Y.-C., Yo, H.-H., Wei, M., & Shen, L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-25 · Cited by 9 · see citing works

Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer

Li, Y., Li, X., Dai, H.-P., Sun, X., Li, J., Yang, F., Gu, H., Yang, Y., Jin, Z., Chu, Y., et al. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08099.x · Cited by 7 · see citing works

Using pegylated arginine deiminase (ADI-PEG20) for the treatment of sarcomas that lack argininosuccinate synthesase 1 expression.

Tine, B. A. V., Bean, G. R., Boone, P. F., Tanas, M. R., Schulze, M. B., Chen, D. Y., Bomalaski, J. S., & Rubin, B. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.10526 · Cited by 3 · see citing works

Abstract 5382: Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma

Chow, A. K.-M., Pang, R. W. C., Chu, A. C. Y., Ng, L., & Poon, R. T. P. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-5382 · Cited by 2 · see citing works

Understanding the Intersections between Metabolism and Cancer Biology

Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works

Autophagy and autophagy-related pathways in cancer

Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,446 · see citing works

The cancer metabolic reprogramming and immune response

Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312 · see citing works

Serine and one-carbon metabolism in cancer

Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992 · see citing works

Targeting Metabolism for Cancer Therapy

Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works

Nitric oxide synthase in innate and adaptive immunity: an update

Bogdan, C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.003 · Cited by 862 · see citing works

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 649 · see citing works

New aspects of amino acid metabolism in cancer

Vettore, L. A., Westbrook, R. L., & Tennant, D. A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0620-5 · Cited by 503 · see citing works

Myeloid Cell-Derived Arginase in Cancer Immune Response

Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzyńska, Z., Jasiński, M., Nowis, D., & Gołąb, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00938 · Cited by 434 · see citing works

Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors

Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 368 · see citing works

Rewiring urea cycle metabolism in cancer to support anabolism

Keshet, R., Szlosarek, P. W., Carracedo, A., & Erez, A. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0054-z · Cited by 322 · see citing works

Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy

Tajan, M., Hennequart, M., Cheung, E. C., Zani, F., Hock, A. K., Legrave, N. M., Maddocks, O. D. K., Ridgway, R. A., Athineos, D., Suárez‐Bonnet, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20223-y · Cited by 307 · see citing works

Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity

Rodrı́guez, P. C., Ochoa, A. C., & Al-Khami, A. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00093 · Cited by 287 · see citing works

l -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells

Fletcher, M., Ramírez, M. E., Sierra, R. A., Raber, P. L., Thevenot, P., Al-Khami, A. A., Sanchez‐Pino, M. D., Hernandez, C., Wyczechowska, D. D., Ochoa, A. C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1491 · Cited by 283 · see citing works

Arginine dependence of tumor cells: targeting a chink in cancer’s armor

Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 268 · see citing works

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications

Gandhi, N. S., & Das, G. M. (2019) · Cells · doi:10.3390/cells8020089 · Cited by 227 · see citing works

Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy

Gupta, S., Roy, A., & Dwarakanath, B. S. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 218 · see citing works

The Diverse Functions of Non-Essential Amino Acids in Cancer

Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213 · see citing works

Dietary Approaches to Cancer Therapy

Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 208 · see citing works

Targeting amino acid metabolism in cancer growth and anti-tumor immune response

Ananieva, E. A. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.281 · Cited by 198 · see citing works

Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond

Ananieva, E. A., Powell, J. D., & Hutson, S. M. (2016) · Advances in Nutrition · doi:10.3945/an.115.011221 · Cited by 192 · see citing works

Targeting arginine metabolism pathway to treat arginine-dependent cancers

Qiu, F., Huang, J., & Sui, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.020 · Cited by 158 · see citing works

Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy

Xiong, L., Teng, J. L. L., Botelho, M. G., Lo, R. C., Lau, S. K. P., & Woo, P. C. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030363 · Cited by 152 · see citing works

Tumour metabolism and its unique properties in prostate adenocarcinoma

Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 154 · see citing works

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice

Lasorsa, F. M., di Meo, N. A., Rutigliano, M., Milella, M., Ferro, M., Pandolfo, S. D., Crocetto, F., Tătaru, O. S., Riccardo Autorino, B., Battaglia, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11041071 · Cited by 145 · see citing works

Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo

Miraki‐Moud, F., Ghazaly, E. A., Ariza‐McNaughton, L., Hodby, K. A., Clear, A. J., Anjos‐Afonso, F., Liapis, K., Grantham, M., Sohrabi, F., Cavenagh, J. D., et al. (2015) · Blood · doi:10.1182/blood-2014-10-608133 · Cited by 139 · see citing works

The Janus-like role of proline metabolism in cancer

Burke, L. E. C.-A., Guterman, I., Palacios-Gallego, R., Britton, R. G., Burschowsky, D., Tufarelli, C., & Rufini, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00341-8 · Cited by 128 · see citing works

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers

Beddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., Corbacho, J. G., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 121 · see citing works

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside

Yin, Y., Feng, W., Chen, J., Chen, X., Wang, G., Wang, S., Xu, X., Nie, Y., Fan, D., Wu, K., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00539-x · Cited by 119 · see citing works

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Wang, J., He, Y., Hu, F., Hu, C., Sun, Y., Yang, K., & Yang, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212223 · Cited by 112 · see citing works

Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression

Matos, A., Carvalho, M., Bicho, M., & Ribeiro, R. J. T. (2021) · Nutrients · doi:10.3390/nu13124503 · Cited by 106 · see citing works

Dysbiosis of skin microbiome and gut microbiome in melanoma progression

Mekadim, C., Skalníková, H. K., Čížková, J., Cizkova, V., Palanová, A., Horák, V., & Mrázek, J. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02458-5 · Cited by 94 · see citing works

Perioperative dynamics and significance of amino acid profiles in patients with cancer

Gu, Y. X., Chen, T., Fu, S.-Z., Sun, X., Wang, L., Wang, J., Lu, Y., Ding, S., Ruan, G., Teng, L., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0408-1 · Cited by 90 · see citing works

Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes

Alexandrou, C., Al-Aqbi, S. S., Higgins, J. A., Boyle, W., Karmokar, A., Andreadi, C., Luo, J., Moore, D. A., Viskaduraki, M., Blades, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30591-7 · Cited by 86 · see citing works

Arginine deprivation in cancer therapy

Feun, L. G., Kuo, M. T., & Savaraj, N. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000122 · Cited by 84 · see citing works

Fueling T-cell Antitumor Immunity: Amino Acid Metabolism Revisited

Han, C., Ge, M., Ho, P., & Zhang, L. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0459 · Cited by 83 · see citing works

A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma

Lowery, M. A., Yu, K. H., Kelsen, D. P., Harding, J. J., Bomalaski, J. S., Glassman, D. C., Covington, C. M., Brenner, R., Hollywood, E. M., Barba, A., et al. (2017) · Cancer · doi:10.1002/cncr.30897 · Cited by 79 · see citing works

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Tsai, H., Jiang, S. S., Hung, W.-C., Borthakur, G. M., Lin, S.-F., Pemmaraju, N., Jabbour, E. J., Bomalaski, J. S., Chen, Y., Hsiao, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10542-4 · Cited by 77 · see citing works

Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level

Pillozzi, S., Bernini, A., Palchetti, I., Crociani, O., Antonuzzo, L., Campanacci, D. A., & Scoccianti, G. (2021) · Cancers · doi:10.3390/cancers13123044 · Cited by 76 · see citing works

Research progress in inducing immunogenic cell death of tumor cells

Xie, D., Wang, Q., & Wu, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1017400 · Cited by 74 · see citing works

Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy

Kuo, M. T., Chen, H., Feun, L. G., & Savaraj, N. (2021) · Pharmaceuticals · doi:10.3390/ph14010072 · Cited by 72 · see citing works

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor

Zou, Z., Hu, X., Luo, T., Ming, Z., Chen, X., Li, X., Luo, W., Li, J., Xu, N., Chen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22235-8 · Cited by 70 · see citing works

Arginine Metabolism and Its Potential in Treatment of Colorectal Cancer

Du, T., & Han, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658861 · Cited by 70 · see citing works

Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming

Chen, M., Zhang, C., Liu, W., Du, X., Liu, X., & Xing, B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.020 · Cited by 70 · see citing works

Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy

McAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67 · see citing works

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes

Zhao, H., Heimberger, A. B., Lu, Z., Wu, X., Hodges, T. R., Song, R., & Shen, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7974 · Cited by 67 · see citing works

Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

Prudner, B. C., Rathore, R., Robinson, A. M., Godec, A., Chang, S. F., Hawkins, W. G., Hirbe, A. C., & Tine, B. A. V. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0206 · Cited by 66 · see citing works

Metabolic synthetic lethality in cancer therapy

Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 62 · see citing works

Arginine deprivation by arginine deiminase ofStreptococcus pyogenescontrols primary glioblastoma growthin vitroandin vivo

Fiedler, T., Strauß, M., Hering, S., Redanz, U., William, D., Rosche, Y., Classen, C. F., Kreikemeyer, B., Linnebacher, M., & Maletzki, C. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1026478 · Cited by 63 · see citing works

Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation

Long, Y., Tsai, W.-B., Chang, J. T., Estecio, M. R., Wangpaichitr, M., Savaraj, N., Feun, L. G., Chen, H. H. W., & Kuo, M. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12308 · Cited by 62 · see citing works

Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism

Yeon, A., You, S., Kim, M., Gupta, A., Park, M. H., Weisenberger, D. J., Liang, G., & Kim, J. (2018) · Theranostics · doi:10.7150/thno.25130 · Cited by 61 · see citing works

Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity

El‐Sayed, A. S. A., Shindia, A. A., Abou-Zeid, A. A., Yassin, A. M., Sitohy, M. Z., & Sitohy, B. (2019) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2019.109432 · Cited by 61 · see citing works

Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy

Jahani, M., Noroznezhad, F., & Mansouri, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.109 · Cited by 60 · see citing works

The interplay between metabolic remodeling and immune regulation in glioblastoma

Kesarwani, P., Kant, S., Prabhu, A. H., & Chinnaiyan, P. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox079 · Cited by 55 · see citing works

PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration

Brin, E., Wu, K., Lu, H.-T., He, Y., Dai, Z., & He, W. (2017) · Oncotarget · doi:10.18632/oncotarget.19564 · Cited by 55 · see citing works

Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells

Yeh, T.-H., Chen, Y.-R., Chen, S., Shen, W., Ann, D. K., Zaro, J. L., & Shen, L. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00706 · Cited by 53 · see citing works

Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation

Lee, H., Jedrychowski, M. P., Vinayagam, A., Wu, N., Shyh‐Chang, N., Hu, Y., Min-Wen, C., Moore, J. K., Asara, J. M., Lyssiotis, C. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.074 · Cited by 49 · see citing works

Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy

long, Y. N., Tsai, W.-B., Wang, D., Hawke, D. H., Savaraj, N., Feun, L. G., Hung, M., Chen, H. H. W., & Kuo, M. T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.028 · Cited by 51 · see citing works

Amino Acid Degrading Enzymes and their Application in Cancer Therapy

Pokrovsky, V. S., Chepikova, O. E., Давыдов, Д. Ж., Zamyatnin, A. A., Lukashev, A. N., & Lukasheva, E. V. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171006132729 · Cited by 50 · see citing works

Isolation and screening of extracellular anticancer enzymes from halophilic and halotolerant bacteria from different saline environments in Iran

Zolfaghar, M., Amoozegar, M. A., Khajeh, K., Babavalian, H., & Tebyanian, H. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04787-7 · Cited by 49 · see citing works

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints

Xu, Y., He, L., Fu, Q., & Hu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759015 · Cited by 49 · see citing works

Argininosuccinate lyase is a potential therapeutic target in breast cancer

Huang, H.-L., Chen, W.-C., Hsu, H., Cho, C.-Y., Hung, Y.-H., Wang, C., & Lai, M.-D. (2015) · Oncology Reports · doi:10.3892/or.2015.4280 · Cited by 47 · see citing works

Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma

Chen, J., Wang, R., Liu, Z., Fan, J., Liu, S., Tan, S., Li, X., Li, B., & Yang, X. (2022) · Cells · doi:10.3390/cells11233924 · Cited by 46 · see citing works

Arginine deprivation and autophagic cell death in cancer

Szlosarek, P. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416560111 · Cited by 46 · see citing works

Streptavidin-mirror DNA tetrahedron hybrid as a platform for intracellular and tumor delivery of enzymes

Kim, K., Hwang, D., Kim, J., Lee, C.-Y., Lee, W., Yoon, D. S., Shin, D., Min, S., Kwon, I. C., Chung, H. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.051 · Cited by 46 · see citing works

Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts

Hang, D., Yang, X., Lu, J., Shen, C., Dai, J., Lu, X., Jin, G., Hu, Z., Gu, D., Ma, H., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34229 · Cited by 45 · see citing works

The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials

Synakiewicz, A., Stachowicz‐Stencel, T., & Adamkiewicz‐Drożyńska, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.934808 · Cited by 45 · see citing works

Research into cancer metabolomics: Towards a clinical metamorphosis

Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E., & Halsey, C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.008 · Cited by 45 · see citing works

Arginine deprivation induces endoplasmic reticulum stress in human solid cancer cells

Bobak, Y. P., Kurlishchuk, Y. V., Vynnytska‐Myronovska, B., Grydzuk, O., Shuvayeva, G., Rędowicz, M. J., Kunz‐Schughart, L. A., & Stasyk, O. V. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.027 · Cited by 44 · see citing works

Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug

Han, R., Xu, G., Dong, J., & Ni, Y. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7490-z · Cited by 43 · see citing works

Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma

Tao, X., Zuo, Q., Ruan, H., Wang, H., Jin, H., Cheng, Z., Lv, Y., Qin, W., & Wang, C. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz005 · Cited by 44 · see citing works

Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability

Werner, A., Pieh, D., Echchannaoui, H., Rupp, J., Rajalingam, K., Theobald, M., Closs, E. I., & Munder, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01268 · Cited by 44 · see citing works

Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer

Daylami, R., Muilenburg, D. J., Virudachalam, S., & Bold, R. J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-8245834981349245 · Cited by 43 · see citing works

Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers

Pathria, G., & Ronai, Z. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.009 · Cited by 42 · see citing works

Recombinant arginine‐degrading enzymes in metabolic anticancer therapy and bioanalytics

Stasyk, O. V., Boretsky, Y. R., Gonchar, M. V., & Sibirny, A. А. (2014) · Cell Biology International · doi:10.1002/cbin.10383 · Cited by 39 · see citing works

Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization

Hinrichs, C. N., Ingargiola, M., Käubler, T., Löck, S., Temme, A., Köhn‐Luque, A., Deutsch, A., Vovk, O. I., Stasyk, O. V., & Kunz‐Schughart, L. A. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0807 · Cited by 39 · see citing works

Searching for targets for the systemic therapy of mesothelioma

Stahel, R. A., Weder, W., Felley‐Bosco, E., Petrausch, U., Fontecedro, A. C., Schmitt-Opitz, I., & Peters, S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv101 · Cited by 38 · see citing works

Role of amino acid metabolism in angiogenesis

Oberkersch, R. E., & Santoro, M. M. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.11.001 · Cited by 38 · see citing works

The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?

Bronte, G., Incorvaia, L., Rizzo, S., Passiglia, F., Galvano, A., Rizzo, F., Rolfo, C. D., Fanale, D., Listì, A., Natoli, C., et al. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.08.011 · Cited by 38 · see citing works

A virulence factor as a therapeutic: the probiotic Enterococcus faecium SF68 arginine deiminase inhibits innate immune signaling pathways

Ghazisaeedi, F., Meens, J., Hansche, B. F., Maurischat, S., Schwerk, P., Goethe, R., Wieler, L. H., Fulde, M., & Tedin, K. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2106105 · Cited by 37 · see citing works

Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer

Hall, P. E., Ready, N., Johnston, A. L., Bomalaski, J. S., Venhaus, R. R., Sheaff, M. T., Krug, L. M., & Szlosarek, P. W. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.07.012 · Cited by 35 · see citing works

Identification of metabolites in plasma for predicting survival in glioblastoma

Shen, J., Song, R., Hodges, T. R., Heimberger, A. B., & Zhao, H. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22815 · Cited by 34 · see citing works

Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1

Agnello, G., Alters, S. E., & Rowlinson, S. W. (2019) · Translational research · doi:10.1016/j.trsl.2019.12.005 · Cited by 34 · see citing works

Designing Smart Materials with Recombinant Proteins

Hollingshead, S. E., Lin, C., & Liu, J. C. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201600554 · Cited by 33 · see citing works

Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth

Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0317 · Cited by 33 · see citing works

Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase

Sahu, D., Gupta, S., Hau, A. M., Nakashima, K., Leivo, M. Z., Searles, S. C., Elson, P. J., Bomalaski, J. S., Casteel, D. E., Boss, G. R., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.004 · Cited by 32 · see citing works

Targeting Immunometabolism in Glioblastoma

Mohan, A. A., Tomaszewski, W. H., Haskell-Mendoza, A. P., Hotchkiss, K. M., Singh, K., Reedy, J. L., Fecci, P. E., Sampson, J. H., & Khasraw, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696402 · Cited by 32 · see citing works

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment

Hou, X., Chen, S., Zhang, P., Guo, D., & Wang, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.938847 · Cited by 33 · see citing works

Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment

Kumari, N., & Bansal, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04335-w · Cited by 30 · see citing works

The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives

Ahuja, S., & Zaheer, S. (2024) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.24009 · Cited by 31 · see citing works

Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia

Tsai, H., Hsiao, H., Hsu, Y., Liu, Y., Kao, H., Liu, T., Cho, S., Feng, X., Johnston, A. L., Bomalaski, J. S., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3871 · Cited by 29 · see citing works

Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion

Cao, Y., Ding, W., Zhang, J., Gao, Q., Yang, H.-X., Cao, W., Wang, Z., Fang, L., & Du, R. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00921 · Cited by 29 · see citing works

Liver-resident memory T cells: life in lockdown

Pallett, L. J., & Maini, M. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00932-w · Cited by 28 · see citing works

Metabolomic characterisation of progression and spontaneous regression of melanoma in the melanoma-bearing Libechov minipig model

Kertys, M., Grendár, M., Horák, V., Žideková, N., Skalníková, H. K., Mokrý, J., Halášová, E., & Strnádel, J. (2021) · Melanoma Research · doi:10.1097/cmr.0000000000000722 · Cited by 28 · see citing works

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms

Szlosarek, P. W., Phillips, M. M., Pavlyk, I., Steele, J. P. C., Shamash, J., Spicer, J. F., Kumar, S. S., Pacey, S., Feng, X., Johnston, A. L., et al. (2020) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2020.100093 · Cited by 28 · see citing works

Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy

Nair, R., Gupta, P., & Shanmugam, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000106 · Cited by 28 · see citing works

Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM

Mörén, L., Perryman, R., Crook, T., Langer, J. K., O’Neill, K., Syed, N., & Antti, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4040-3 · Cited by 27 · see citing works

Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer

Mouhid, L., de Cedrón, M. G., García-Carrascosa, E., Reglero, G., Fornari, T., & de Molina, A. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214294 · Cited by 26 · see citing works

Arginine Metabolism in Cancer Biology and Immunotherapy

Bai, D., Zhou, Y., Jing, L., Guo, C., & Yang, Q. (2025) · Immune Network · doi:10.4110/in.2025.25.e30 · Cited by 25 · see citing works

c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma

Ciribilli, Y., Singh, P., Inga, A., & Borlak, J. T. (2016) · Oncotarget · doi:10.18632/oncotarget.11804 · Cited by 25 · see citing works

Arginine Deprivation as a Targeted Therapy for Cancer

Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 235 · see citing works

Bench-to-Bedside Studies of Arginine Deprivation in Cancer

Field, G., Pavlyk, I., & Szlosarek, P. W. (2023) · Molecules · doi:10.3390/molecules28052150 · Cited by 34 · see citing works

Targeting Argininosuccinate Synthetase in Cancer Therapy

Savaraj, N., You, M., Wu, C., Kuo, M. T., Dinh, V., Wangpaichitr, M., & Feun, L. G. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0730-0_3 · Cited by 1 · see citing works

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441 · see citing works

Arginine deprivation in cancer therapy

Feun, L. G., Kuo, M. T., & Savaraj, N. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000122 · Cited by 84 · see citing works